Latin America Blood Screening Market

Latin America Blood Screening Market Size

The Latin America blood screening market was valued at USD 1.31 billion in 2025 and stood at USD 0.34 billion in 2026. The market is projected to reach USD 0.62 billion by 2034, growing at a CAGR of 7.9% from 2026 to 2034.

Blood screening refers to several tests conducted on blood samples to diagnose diseases such as AIDS, hepatitis, and syphilis, as well as other clinical situations such as pregnancy. Thus, it helps detect and prevent diseases and a variety of other disorders like infections and cancer. One of the major factors driving the Latin American blood screening market over the forecast period is increased blood donations among people.

One of the most desirable and favored techniques for diagnosing numerous infectious diseases is blood screening. Blood screening allows doctors to accurately diagnose diseases, which aids in administering appropriate medicines and patient monitoring to prevent disease spread. The market's further expansion can be possible due to increased donor screening and industry participants' continual technical advancement. Blood screening tests are in high demand due to rising donations, increased awareness of transfusion-transmitted diseases, and technological advancements in the business. Furthermore, governments in several nations are working to make it mandatory to test all donated blood for various viruses.

The huge pool of patients, expanding health care infrastructure, increasing disposable income, growing demand for donated blood, and increased government support in the region are other significant market driving forces for the blood screening market in the Latin American region. In addition, pathogen reduction technologies, microbiological screening, and multiplexing (a single test for HIV, HBV, and HCV) would help to expand the market for blood screening.

However, the absence of legislation, regulation, and policies governing blood transfusion-related operations in some countries and the emergence of alternative technologies to blood screening is projected to stymie the market's growth during the forecast period. In addition, a lack of a qualified workforce and high initial capital expenditure and testing expenses are further stifling the Latin American blood screening market's growth.

REPORT COVERAGE

KEY MARKET PLAYERS

Some of the noteworthy companies operating in the Latin American blood screening market.

• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• Ortho Clinical Diagnostics
• Danaher Corporation
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Grifols
• Siemens AG
• Beckman Coulter, Inc.

MARKET SEGMENTATION

This research report on the Latin American blood screening market has been segmented and sub-segmented into the following categories:

By Technology

• Nucleic Acid Amplification
• Elisa
• Rapid Test
• NGS
• Western Blotting

By Product

• Instruments
• Reagent & Kits
• Software

By End User

• Blood banks
• Hospital

By Country:

• Mexico
• Brazil
• Argentina
• Chile
• Rest of Latin America